X4 Pharmaceuticals, Inc.
XFOR
$4.02
$0.030.75%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -7.62% | 107.05% | 94.11% | -27.60% | -14.80% |
| Total Receivables | 94.24% | -64.32% | -13.89% | 58.86% | -31.35% |
| Inventory | 3.53% | 9.78% | 28.71% | 2.62% | 9.66% |
| Prepaid Expenses | -23.42% | -46.31% | -5.15% | 10.55% | -19.77% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -42.27% | 347.77% | -- | -- | -- |
| Total Current Assets | -7.49% | 96.96% | 82.07% | -23.78% | -14.69% |
|
|
|||||
| Total Current Assets | -7.49% | 96.96% | 82.07% | -23.78% | -14.69% |
| Net Property, Plant & Equipment | -25.77% | -20.17% | -31.28% | -29.93% | -14.50% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -2.02% | -1.99% | -1.94% | -1.92% | -1.87% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.73% | -64.84% | -16.26% | -22.00% | 44.86% |
| Total Assets | -6.95% | 77.59% | 55.52% | -19.11% | -11.22% |
|
|
|||||
| Total Accounts Payable | -10.94% | 12.73% | -34.45% | -30.64% | 28.93% |
| Total Accrued Expenses | -8.32% | 13.16% | 25.82% | 3.60% | -45.18% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -26.26% | -17.17% | -12.28% | 4.99% | 4.16% |
| Total Finance Division Other Current Liabilities | 96.12% | -43.00% | 7.96% | -11.81% | -- |
| Total Other Current Liabilities | 96.12% | -43.00% | 7.96% | -11.81% | -- |
| Total Current Liabilities | -7.71% | 9.58% | 2.66% | -11.54% | -21.27% |
|
|
|||||
| Total Current Liabilities | -7.71% | 9.58% | 2.66% | -11.54% | -21.27% |
| Long-Term Debt | 0.30% | 0.30% | 0.29% | 0.28% | 0.27% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -88.34% | -26.51% | -21.35% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -27.46% | -6.60% | 38.18% | -63.01% | -69.51% |
| Total Liabilities | -2.25% | 2.19% | 0.73% | -5.48% | -13.86% |
|
|
|||||
| Common Stock & APIC | 0.31% | 23.50% | 16.05% | 1.26% | 0.10% |
| Retained Earnings | -3.40% | -4.19% | -5.51% | -5.00% | 0.05% |
| Treasury Stock & Other | -11.93% | 7.63% | 14.49% | -7.81% | -4.92% |
| Total Common Equity | -9.58% | 202.33% | 1,451.73% | -82.69% | 3.59% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -9.58% | 202.33% | 1,451.73% | -82.69% | 3.59% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.58% | 202.33% | 1,451.73% | -82.69% | 3.59% |
|
|
|||||